Results 61 to 70 of about 498 (114)
Bacterial infections, particularly those caused by Gram‐positive bacteria like vancomycin‐resistant enterococci (VRE) and methicillin‐resistant Staphylococcus aureus (MRSA), are a growing concern. This review highlights the potential of the Streptomyces genus in producing novel antibacterial compounds against Gram‐positive bacteria.
Soumia Ait Assou +2 more
wiley +1 more source
ABSTRACT Background and Aims Pathogenic microbial infections are closely related to the development and prognosis of esophageal cancer. The distribution and resistance of pathogens in different diseases are regional and gradually change over time. This study aimed to determine the distribution and drug resistance of pathogens isolated from patients ...
Hongwei Meng +5 more
wiley +1 more source
Oritavancin in the Treatment of Infective Endocarditis in IV Drug Abusers [PDF]
2020 clinical vignette posterhttps://digitalcommons.library.uab.edu/uabh-rd-all/1112/thumbnail ...
Al-Baghdadi, Maha, Hassoun, Ali
core +1 more source
Impact on public health of the spread of high-level resistance to gentamicin and vancomycin in enterococci [PDF]
Antibiotic resistance has turned into a global public health issue. Enterococci are intrinsically resistant to many antimicrobials groups. These bacteria colonize dairy and meat products and integrate the autochthonous microbiota of mammal’s ...
Delpech, Gastón +2 more
core +2 more sources
This review aimed to summarize the current literature on antibiotic distribution in orthopedically relevant tissues and settings where dynamic sampling methods have been used. PubMed and Embase databases were systematically searched. English‐published studies between 2004 and 2024 involving systemic antibiotic administration in orthopedically relevant ...
Maria Bech Damsgaard Nielsen +5 more
wiley +1 more source
Background: Dalbavancin and oritavancin are long-acting lipoglycopeptides increasingly used off-label for a variety of Gram-positive infections. While their efficacy has been described in osteomyelitis, bacteremia, and infective endocarditis, evidence ...
Francesca Gavaruzzi +4 more
doaj +1 more source
Semisynthetic glycopeptide antibiotics [PDF]
Vancomycin is a last-resort antibiotic for the treatment of many Gram-positive bacterial infections, while remaining inactive against Gram-negative strains. Resistance to vancomycin in Gram-positive stains continues to develop.
Groesen, E. van
core +1 more source
Abstract Objective To summarize the evidence on the efficacy and safety of vancomycin compared with those of alternative treatments in adult patients with methicillin‐resistant Staphylococcus aureus (MRSA) infection. Methods PubMed, Embase, and Web of Science were searched up to December 15, 2023, for systematic reviews and meta‐analyses comparing ...
Sujata Purja +4 more
wiley +1 more source
Synergistic triple combination antibiotic therapy for Gram-negative bacterial infections : a thesis presented in partial fulfilment of the requirements for the degree of Doctor of Philosophy in Microbiology and Genetics at Massey University, Manawatu, New Zealand [PDF]
Figures are re-used with permission or under a Creative Commons Attribution License (CC-BY).Appendix B Supplementary files 1-5 are available from Figshare https://doi.org/10.6084/m9.figshare.13250396, and files 6-13 from NCBI Sequence Read Archive under ...
Olivera, Catrina Diane
core
Abstract The development of drug‐resistant microorganisms is taking a heavy toll on the biomedical world. Clinical infections are costly and becoming increasingly dangerous as bacteria that once responded to standard antibiotic treatment are developing resistance mechanisms that require innovative treatment strategies.
Lori M. Estes Bright +5 more
wiley +1 more source

